Skip to main content
. 2010 Jan;77(1):46–57. doi: 10.1124/mol.109.058677

TABLE 4.

Results of blood-brain barrier penetration studies for five Y2R antagonists and BIIE0246

ID Brain Penetration Studies
Plasma Concentration Brain Concentration Ratio [B]/[P]
μM %
SF-11 8.5 ± 3.3 3.7 ± 1.7 44
SF-21 1.1 ± 0.1 0.4 ± 0.03 36
SF-22 1.6 ± 0.6 1.7 ± 0.6 106
SF-31 9.0 ± 0.7 4.5 ± 0.3 50
SF-41 1.3 ± 0.3 1.5 ± 0.2 115
BIIE0246 12 ± 2 0.2 ± 0.1 2
HHS Vulnerability Disclosure